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Abstract 
Review on ERGIC3, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Keywords 
ERGIC3; Erv46. 
Identity 
Other names: C20orf47, CGI-54, Erv46, NY-BR-
84, PRO0989, SDBCAG84, dJ477O4.2 
HGNC (Hugo): ERGIC3 
Location: 20q11.22 
Local order: ERGIC3 is located on the forward 
strand of chromosome 20 at 20q11.22 (figure 1.A). 
It is between base pairs 35542029-35557634 (figure 
1.B) and is composed of 15606 nucleotides encoding 
13 or 14 exons (figure 2). NCBI gene ID is 51614. 
Note 
According to hg38/GRCh38-Dec_2013: (GRCh38) 
- ERGIC3 at chr20: 35542029-35557634 
(NM_198398) endoplasmic reticulum-Golgi 
intermediate compartment protein 3 isoform 1 
- ERGIC3 at chr20: 35542029-35557634 
(NM_015966) endoplasmic reticulum-Golgi 
intermediate compartment protein 3 isoform 2 
Figure 1. ERGIC3 chromosomal localization (A) (adapted from GeneCards) and the ERGIC3 gene maps on chromosome 
20q11.22 (B). The red line is the location of ERGIC3 on chromosome 20 (chr20). 
ERGIC3 (ERGIC and golgi 3) Wu M, Cao Y 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(8) 500 
 
 
Figure 2. The transcript variants and coding sequence (CDS) of ERGIC3. 
 
 
DNA/RNA 
Note 
According to hg38/GRCh38-Dec_2013:(GRCh38) 
- Start: chr20: 35542029 bp from pter 
- End: chr20:35557634 bp from pter 
- Size: 15606 bases 
- Orientation: forward strand. 
Transcription 
Two alternatively spliced transcript variants 
encoding different isoforms have been demonstrated 
for this gene. 
Isoform 1 transcript is 1383 bases (RefSeq: 
NM_198398.1), which is comprised of 14 exons and 
coding the longer isoform (Figure 2). 
Isoform 2 represents the shorter 1368 bases, RefSeq: 
NM_015966.2, which is comprised of 13 exons and 
coding the shorter isoform (Figure 2). The open 
reading frame (ORF) is shifted because the variant is 
not spliced. Therefore, compared to isoform 1 the 
protein is shorter. 
Pseudogene 
No observed pseudogenes. 
Protein 
Note 
Human ERGIC3 protein is a type II transmembrane 
protein containing two external membrane areas 
(1~19, 368~383), two transmembrane areas (20~42, 
341~362), as well as a endoplasmic reticulum  
lumen area (43~344) from amino acid residues 
(figure 3). Human ERGIC3 consists of 383 amino 
acid with the molecular mass 43.2 kD and the value 
of theoretical isoelectric point 5.68, (Geng et al., 
2014).  
ERGIC3 protein contains two conserved domains, 
ERGIC_N and COPIIcoated_ERV (figure 3) which 
are localized to the early secretory pathway and are 
involved in protein maturation and processing in the 
endoplasmic reticulum and/or sorting into COPII 
vesicles for transport to the Golgi (Otte et al., 2001). 
There are 2 glycosylation sites in the N241, N266 
(figure 3). 
Description 
388 aa (Accession: NM_198398.1, NP_938408 ) 
isoform 1; 383 aa (Accession: NM_015966.2, 
NP_057050.1). isoform 2. ERGIC3 belongs to the 
family of the ER vesicle (Erv) proteins (Otte et al., 
2001). ERGIC3 interacts with ERGIC2 (Welsh et al., 
2006) and ERGIC1 (Breuza et al., 2004) and forms 
a heterotrimeric protein complex. Both isoforms 
contain ERGIC_N domain and COPIIcoated_ERV 
domain (figure 3) which is conserved from fungi to 
humans.  
ERGIC3 works in close on junction with ERGIC2 
and together they form a complex which cycles 
between the endoplasmic reticulum and cis-Golgi 
network. Both are integral membrane proteins with 
two membrane spanning segments each, short N- 
and C-terminal tails expose to the cytosol, and large 
central luminal domains (figure 3) (Welsh et al., 
2006). 
 
Figure 3. The domains of ERGIC3 protein (adapted from NCBI). aa: amino acid; posttrans. modifi.: posttranslational 
modification. TM: transmembrane domain. 
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Expression 
In normal human tissues, ERGIC3 is found in some 
epitheial cells such as liver, pancreas, stomach, 
intestine, and so on, but is undetected in lung, 
cerebral cortex, cerebellum, heart, spleen, thymus, 
muscle (Lin, 2014).  
In human tumor tissues, ERGIC3 is highly expressed 
in lung cancer, hepatocellular carcinoma, pancreatic 
carcinoma, gastric carcinoma, colon cancer, 
esophagus cancer, but is negative in osteosarcoma, 
chondrosarcoma, and fibrosarcoma by 
immunohistochemical (IHC) staining (Lin, 2014).  
In addtion, ERGIC3 is highly expressed in the spinal 
cord and kidney of mouse (Nishikawa et al., 2007). 
Localisation 
ERGIC3 mainly localizes to endoplasmic reticulum, 
endoplasmic reticulum-golgi intermediate 
compartment (ERGIC) and cis-Golgi network, 
(Breuza et al., 2004; Orci et al., 2003; Wu et al., 
2013). 
Function 
The precise function of ERGIC3 is presently unclear, 
especially in mammal cells. There is a strong 
interaction between ERGIC3 and ERGIC2 so as to 
form a heteromer complex which exerting its 
biological function. The complex may be involved in 
: 1) the sorting of some secretory molecules during 
vesiclar transport (Belden and Barlowe, 2001; Otte 
and Barlowe, 2004) due to the hydrophobic signals 
present on both C-terminal tails of the ERGIC3-
ERGIC2 complex control sorting into COPII 
vesicles for anterograde transport, and retrieval from 
the Golgi is mediated by a COPI binding KKxx motif 
on ERGIC3 (Otte and Barlowe, 2002) ; 2) protein 
folding and glycoprotein processing in the 
endoplasmic reticulum and cis- Golgi network 
(Nishikawa et al., 2007; Welsh et al., 2006). 
Glucosidase II is not transported into COPII vesicles 
in vitro as well as cells lacking a cycling ERGIC3-
ERGIC2 complex have a mild glycoprotein 
processing defect and a partial loss of glucosidase 
(Leah, 2006) inhibiting endoplasmic reticulum stress 
(ERS)-induced cell death by tunicamycin in HEK-
293 cells (Nishikawa et al., 2007). 
Homology 
ERGIC3 is highly conserved in species. The amino 
acid sequence is at least 98% among 8 vertebrates, 
human, pongo, macaca, ailuropoda, myotis, bovini, 
mus, heterocephalus. There is only one change in 
amino acid (T164) between human and pongo, 2 
changes in amino acid (T112, W170) between 
human and macaca (Geng et al., 2014). 
Mutations 
Note 
No observed mutation sites. 
Implicated in 
Non-small cell lung cancer (NSCLC) 
Note 
ERGIC3 is highly up-regulated in NSCLC. A study 
(Wu et al., 2013) demonstrated that ERGIC3 was 
positive in 89% of NSCLCs while ERGIC3 was not 
detected in normal bronchial epithelial cells and 
alveolar cells.  
Moreover, the positive rate of lung adenocarcinoma 
was higher than that of lung squamous cell 
carcinoma, and the positive rate of poorly 
differentiated NSCLCs was higher than that of the 
well and moderately differentiated NSCLCs.  
The study suggested that ERGIC3 may be a potential 
biomarker for lung cancer.  
Additionally, the over-expression of ERGIC3 
promotes the cell proliferation, migration, and 
invasion in NSLCs (Wu et al., 2013). 
Hepatocellular carcinoma (HCC) 
Note 
ERGIC3 was up-regulated in HCC.  
The over-expression of ERGIC3 modulates the 
epithelial to mesenchymal transition (EMT), and 
increases the cell proliferation, migration, and 
invasion in HCCs (Zhang et al., 2013). Furthermore, 
ERGIC3 expression is regulated by MiR-490-3p 
(Zhang et al., 2013). 
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